Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
76
Frequently Asked Questions
What is Market Cap of Alto Neuroscience Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alto Neuroscience Inc. market cap is $103.43M.
What is the 52-week high for Alto Neuroscience Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alto Neuroscience Inc. 52 week high is $15.04 as of September 18, 2025.
What is the 52-week low for Alto Neuroscience Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alto Neuroscience Inc. 52 week low is $1.60 as of September 18, 2025.
What is Alto Neuroscience Inc. stock price today?
Alto Neuroscience Inc. stock price today is $3.82.
What was Alto Neuroscience Inc. stock price yesterday?
Alto Neuroscience Inc. stock price yesterday was $3.95.
What is the PE ratio of Alto Neuroscience Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alto Neuroscience Inc.’s P/E ratio is -1.59.
What is the Price-to-Book ratio of Alto Neuroscience Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alto Neuroscience Inc. P/B ratio is 0.8380.
What is the 50-day moving average of Alto Neuroscience Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alto Neuroscience Inc. 50-day moving average is $3.30.
How many employess does Alto Neuroscience Inc. has?
